Literature DB >> 10886142

IgA antineutrophil cytoplasmic antibodies in cutaneous vasculitis.

P Rovel-Guitera1, M C Diemert, J L Charuel, J L Laporte, L Musset, O Chosidow, J C Piette, C Francès.   

Abstract

BACKGROUND: Antineutrophil cytoplasmic antibodies (ANCA) of the IgA isotype have, for the most part, been detected in patients with Henoch-Schönlein purpura (HSP) or inflammatory bowel disease.
OBJECTIVES: We have evaluated the prevalence of IgA ANCA in a series of patients with different causes of cutaneous vasculitis.
METHODS: Forty consecutive patients with histologically proven leucocytoclastic vasculitis were included in the study: 18 had systemic vasculitis as well as cutaneous lesions, 10 of whom were diagnosed as having HSP, and 22 had only cutaneous vasculitis (with no identified cause in 10 cases). IgA ANCA were sought by indirect immunofluorescence using ethanol-fixed human neutrophil preparations as the substrate.
RESULTS: IgA ANCA were detected in six of 40 patients (15%) (one each with HSP, ulcerative colitis, Sjögren's syndrome, hypergammaglobulinaemia associated with Castelman's disease, erythema elevatum diutinum and bacterial endocarditis). Three of these patients also had IgG ANCA whose target antigen remained unidentified.
CONCLUSIONS: IgA ANCA are rarely observed in HSP (10%) and can be detected in a wide variety of other cutaneous vasculitides.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10886142     DOI: 10.1046/j.1365-2133.2000.03597.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  8 in total

1.  IgA and IgG antineutrophil cytoplasmic antibody engagement of Fc receptor genetic variants influences granulomatosis with polyangiitis.

Authors:  James M Kelley; Paul A Monach; Chuanyi Ji; Yebin Zhou; Jianming Wu; Sumiaki Tanaka; Alfred D Mahr; Sharleen Johnson; Carol McAlear; David Cuthbertson; Simon Carette; John C Davis; Paul F Dellaripa; Gary S Hoffman; Nader Khalidi; Carol A Langford; Phillip Seo; E William St Clair; Ulrich Specks; John H Stone; Robert F Spiera; Steven R Ytterberg; Peter A Merkel; Jeffrey C Edberg; Robert P Kimberly
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-06       Impact factor: 11.205

2.  IgA antibodies to myeloperoxidase in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss).

Authors:  Esha Oommen; Amber Hummel; Lisa Allmannsberger; David Cuthbertson; Simon Carette; Christian Pagnoux; Gary S Hoffman; Dieter E Jenne; Nader A Khalidi; Curry L Koening; Carol A Langford; Carol A McAlear; Larry Moreland; Philip Seo; Antoine Sreih; Steven R Ytterberg; Peter A Merkel; Ulrich Specks; Paul A Monach
Journal:  Clin Exp Rheumatol       Date:  2017-03-01       Impact factor: 4.473

Review 3.  Vasculitis in Sjögren's Syndrome.

Authors:  R Hal Scofield
Journal:  Curr Rheumatol Rep       Date:  2011-12       Impact factor: 4.592

4.  The significance of IgA class of antineutrophil cytoplasmic antibodies (ANCA) in childhood Henoch-Schönlein purpura.

Authors:  Fatih Ozaltin; Aysin Bakkaloglu; Seza Ozen; Rezan Topaloglu; Umut Kavak; Mukaddes Kalyoncu; Nesrin Besbas
Journal:  Clin Rheumatol       Date:  2004-06-18       Impact factor: 2.980

Review 5.  Wegener's granulomatosis: a model of auto-antibodies in mucosal autoimmunity.

Authors:  James M Kelley; Jeffrey C Edberg; Robert P Kimberly
Journal:  Clin Immunol       Date:  2009-05-23       Impact factor: 3.969

6.  IgA- and SIgA anti-PR3 antibodies in serum versus organ involvement and disease activity in PR3-ANCA-associated vasculitis.

Authors:  C Sandin; P Eriksson; M Segelmark; T Skogh; A Kastbom
Journal:  Clin Exp Immunol       Date:  2016-02-25       Impact factor: 4.330

Review 7.  Multicentric Castleman's disease associated with IgA vasculitis (Henoch-Schönlein purpura) responding well to tocilizumab: a case report.

Authors:  Yoichi Oshima; Junichi Hoshino; Tatsuya Suwabe; Noriko Hayami; Masayuki Yamanouchi; Akinari Sekine; Toshiharu Ueno; Hiroki Mizuno; Junko Yabuuchi; Aya Imafuku; Masahiro Kawada; Rikako Hiramatsu; Eiko Hasegawa; Naoki Sawa; Kenmei Takaichi; Nobukazu Hayashi; Takeshi Fujii; Yoshifumi Ubara
Journal:  Clin Rheumatol       Date:  2017-02-06       Impact factor: 3.650

8.  Type I interferon response and vascular alteration in chilblain-like lesions during the COVID-19 outbreak.

Authors:  L Frumholtz; J-D Bouaziz; M Battistella; J Hadjadj; R Chocron; D Bengoufa; H Le Buanec; L Barnabei; S Meynier; O Schwartz; L Grzelak; N Smith; B Charbit; D Duffy; N Yatim; A Calugareanu; A Philippe; C L Guerin; B Joly; V Siguret; L Jaume; H Bachelez; M Bagot; F Rieux-Laucat; S Maylin; J Legoff; C Delaugerre; N Gendron; D M Smadja; C Cassius
Journal:  Br J Dermatol       Date:  2021-10-05       Impact factor: 11.113

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.